Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Cyclic peptides
Reexamination Certificate
2003-03-24
2010-06-15
Gupta, Anish (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Cyclic peptides
C514S010100
Reexamination Certificate
active
07737252
ABSTRACT:
This invention relates to new peptide-based compounds and their use in therapeutically effective treatments as well as for diagnostic imaging techniques. More specifically the invention relates to the use of such peptide-based compounds used as targeting vectors that bind to receptors associated with angiogenesis, in particular the αvβ3 integrin receptor. Such contrast agents may thus be used for diagnosis of for example malignant diseases, heart diseases, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma. Moreover such compounds may also be used in therapeutic treatment of these diseases.
REFERENCES:
patent: 4647447 (1987-03-01), Gries et al.
patent: 4770183 (1988-09-01), Groman et al.
patent: 4863715 (1989-09-01), Jacobsen et al.
patent: 5078985 (1992-01-01), Rhodes
patent: 5228446 (1993-07-01), Unger et al.
patent: 5364613 (1994-11-01), Sieving et al.
patent: 5367080 (1994-11-01), Toner et al.
patent: 5387080 (1995-02-01), Bouhennicha et al.
patent: 5846782 (1998-12-01), Wickham et al.
patent: 6559279 (2003-05-01), Manoharan et al.
patent: 7351790 (2008-04-01), Cuthbertson et al.
patent: 0554213 (1993-08-01), None
patent: 0578083 (1994-01-01), None
patent: WO85/02772 (1985-07-01), None
patent: WO89/00557 (1989-01-01), None
patent: WO90/14103 (1990-11-01), None
patent: WO90/15818 (1990-12-01), None
patent: WO91/15243 (1991-10-01), None
patent: WO92/17212 (1992-10-01), None
patent: WO93/05818 (1993-04-01), None
patent: WO95/14714 (1995-06-01), None
patent: WO95/25543 (1995-09-01), None
patent: WO95/26205 (1995-10-01), None
patent: WO96/09840 (1996-04-01), None
patent: WO96/11023 (1996-04-01), None
patent: WO96/17628 (1996-06-01), None
patent: WO96/23524 (1996-08-01), None
patent: WO97/06791 (1997-02-01), None
patent: WO97/10507 (1997-03-01), None
patent: WO97/25073 (1997-07-01), None
patent: WO97/28830 (1997-08-01), None
patent: WO97/29783 (1997-08-01), None
patent: WO98/10795 (1998-03-01), None
patent: WO98/23297 (1998-06-01), None
patent: WO98/47541 (1998-10-01), None
patent: WO98/54346 (1998-12-01), None
patent: WO98/54347 (1998-12-01), None
patent: WO99/39734 (1999-08-01), None
patent: WO99/40214 (1999-08-01), None
Merrifield, Solid Phase Peptide Synthesis (J. Am. Chem. Socl, 85: 2149 (1964).
Haubner, et.al, J. Nucl. Med. (1999) 40: 1061-1071.
Bohlken Craig
GE Healthcare AS
Gupta Anish
LandOfFree
Peptide-based compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide-based compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-based compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4250841